The multi-kinase inhibitor lenvatinib interacts with the HDAC inhibitor entinostat to kill liver cancer cells
Jane L. Roberts, Andrew Poklepovic, Laurence Booth, Paul Dent
Topics & Concepts
LenvatinibCancer researchHistone deacetylase inhibitorSorafenibHistone deacetylaseKinaseCancer cellAutophagyCancerPharmacologyChemistryBiologyCell biologyApoptosisBiochemistryHistoneGeneHepatocellular carcinomaGeneticsHistone Deacetylase Inhibitors ResearchAutophagy in Disease and TherapyProtein Degradation and Inhibitors